chr12-114398568-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_181486.4(TBX5):c.510+5G>A variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_181486.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX5 | NM_181486.4 | c.510+5G>A | splice_region_variant, intron_variant | Intron 5 of 8 | ENST00000405440.7 | NP_852259.1 | ||
TBX5 | NM_000192.3 | c.510+5G>A | splice_region_variant, intron_variant | Intron 5 of 8 | NP_000183.2 | |||
TBX5 | NM_080717.4 | c.360+5G>A | splice_region_variant, intron_variant | Intron 4 of 7 | NP_542448.1 | |||
TBX5 | XM_017019912.2 | c.558+5G>A | splice_region_variant, intron_variant | Intron 5 of 8 | XP_016875401.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Holt-Oram syndrome Pathogenic:1Uncertain:1
- -
- -
Aortic valve disease 2 Uncertain:1
This sequence change falls in intron 5 of the TBX5 gene. It does not directly change the encoded amino acid sequence of the TBX5 protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with TBX5-related conditions (PMID: 30552424; internal data). ClinVar contains an entry for this variant (Variation ID: 519342). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The c.510+5G>A intronic variant results from a G to A substitution 5 nucleotides after coding exon 4 in the TBX5 gene. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. This nucleotide position is highly conserved in available vertebrate species. Using two different splice site prediction tools, this alteration is predicted by BDGP to abolish the native splice donor site, but is predicted to weaken (but not abolish) the efficiency of the native splice donor site by ESEfinder. However, direct evidence is unavailable. Another alteration affecting the canonical sequence at this splice donor site, c.510+1G>T (also reported as IVS5+1G>T), has been reported in a subject with Holt-Oram syndrome who also had a missense alteration in TBX5 (McDermott DA. Pediatr. Res. 2005 Nov;58(5):981-6.). In addition, loss of function of TBX5 has been established as a mechanism of disease. However, since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at